Procter & Gamble Health Ltd Share Price & Stock Analysis

Procter & Gamble Health Ltd (BSE: 500126) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹9,638 Cr, it ranks #604 by market cap among the 6,197 Indian listed companies on FinBizNet, and #20 of 86 in Medicinal Chemicals and Botanical Products. At ₹5,870.00 (as of 16 Nov 2026), the share price is 15.8% below its 52-week high of ₹6,975.00 and 24.7% above its 52-week low of ₹4,707.00. The share price is down 3.1% over one year and down 1.9% over three months.

Key Metrics

Current Price₹5,870.00
Market Cap₹9,638 Cr
BSE Code500126
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio29.3
Return on Equity61.59%
Return on Assets33.24%
52-Week Range₹4,707.00 – ₹6,975.00
1-Year Price Change-3.1%
3-Month Price Change-1.9%
Beta (1Y)0.15
Dividend Yield1.56%
HeadquartersMumbai, Maharashtra
Websitewww.pghealthindia.com

Latest Quarterly Results — Q2 FY27

Revenue₹382 Cr
Net Profit₹112 Cr
Net Margin29.2%
EPS (Basic)₹67.18
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Procter & Gamble Health Ltd Quarterly Revenue and Profit Trend

Procter & Gamble Health Ltd reported revenue of ₹382 Cr in Q2 FY27, up 17.7% from ₹325 Cr in Q2 FY26 and up 5.2% from ₹364 Cr in Q1 FY27. It posted a net profit of ₹112 Cr for the quarter, against a net profit of ₹89 Cr in Q2 FY26 (up 25.9%). Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹325 Cr (Q2 FY26) to ₹382 Cr (Q2 FY27). The company was profitable in each of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹382 Cr₹112 Cr29.2%
Q1 FY27₹364 Cr₹96 Cr26.4%
Q4 FY26₹370 Cr₹95 Cr25.5%
Q3 FY26₹374 Cr₹78 Cr20.8%
Q2 FY26₹325 Cr₹89 Cr27.2%
Q1 FY26₹339 Cr₹66 Cr19.5%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 51.82% of Procter & Gamble Health Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 52.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Products and Services

1. Segment Adjustment-This segment engages in the pharmaceuticals business. 2. Pharmaceuticals-0 3. Chemicals-This segment offers bulk drugs and pigments. 4. Corporate-0

Business Segments

1. Pharmaceuticals-100%

Procter & Gamble Health Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Procter & Gamble Health Ltd₹9,638 Cr29.361.59%₹382 Cr-3.1%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd is trading at ₹5,870.00, with a market capitalisation of ₹9,638 Cr.

Which sector does Procter & Gamble Health Ltd belong to?

Procter & Gamble Health Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd has a P/E of 29.3 and a return on equity of 61.59%.

What is the stock symbol of Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd is listed on the BSE under the scrip code 500126.

How has Procter & Gamble Health Ltd's share price moved over the past year?

Procter & Gamble Health Ltd's share price is down 3.1% over one year and down 1.9% over three months. Its 52-week range is ₹4,707.00 to ₹6,975.00.

What were Procter & Gamble Health Ltd's latest quarterly results?

In Q2 FY27, Procter & Gamble Health Ltd reported revenue of ₹382 Cr and net profit of ₹112 Cr, with basic EPS of ₹67.18 (standalone, parsed from the company's exchange filing).

How have Procter & Gamble Health Ltd's revenue and profit changed over the past year?

Procter & Gamble Health Ltd reported revenue of ₹382 Cr in Q2 FY27, up 17.7% from ₹325 Cr in Q2 FY26 and up 5.2% from ₹364 Cr in Q1 FY27.

What is the promoter holding in Procter & Gamble Health Ltd?

Promoters held 51.82% of Procter & Gamble Health Ltd's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.